BB-031

BOSTON, U.S. & CAMBRIDGE, U.K. — August 25, 2026 Apollo Therapeutics announced positive immunogenicity and cross-species activity data from...

TOKYO, Japan — August 25, 2026 BioCryst Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...

RESEARCH TRIANGLE, North Carolina — August 25, 2026 Basking Biosciences announced positive topline Phase 1 data for BB-025, an...

CAMBRIDGE, Mass., July 30, 2026 CREATE Medicines has received Human Research Ethics Committee (HREC) approval in Australia to initiate...

RESEARCH TRIANGLE, N.C., July 30, 2026 Basking Biosciences has announced the publication of groundbreaking preclinical research in Communications Biology,...